382 related articles for article (PubMed ID: 9744348)
21. [Thyroid scintigraphy and body scanning with 67 Ga in a case of primary thyroid lymphoma].
Hervás Benito I; Vera Espallardo F; Saura Quiles A; González Cabezas P; Bello Arques P; Rivas Sánchez A; Alonso Monfort J; Pérez Velasco R; Mateo Navarro A
Rev Esp Med Nucl; 2001 Oct; 20(6):462-5. PubMed ID: 11578581
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 1999 Feb; 210(2):487-91. PubMed ID: 10207434
[TBL] [Abstract][Full Text] [Related]
23. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
Zijlstra JM; Hoekstra OS; Raijmakers PG; Comans EF; van der Hoeven JJ; Teule GJ; Jonkhoff AR; v Tinteren H; Lammertsma AA; Huijgens PC
Br J Haematol; 2003 Nov; 123(3):454-62. PubMed ID: 14617005
[TBL] [Abstract][Full Text] [Related]
24. [Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].
Ruiz Hernández G; Pallardó-Calatayud J; Ferrer Albiach C; Balaguer-Martínez JV; Romero-de-Avila C; Castillo-Pallarés FJ
Rev Esp Med Nucl; 2001 Feb; 20(1):27-31. PubMed ID: 11181327
[TBL] [Abstract][Full Text] [Related]
25. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2000 Jun; 85(6):613-8. PubMed ID: 10870118
[TBL] [Abstract][Full Text] [Related]
26. The role of the gallium scan in primary extranodal lymphoma.
Hussain R; Christie DR; Gebski V; Barton MB; Gruenewald SM
J Nucl Med; 1998 Jan; 39(1):95-8. PubMed ID: 9443744
[TBL] [Abstract][Full Text] [Related]
27. Gallium-67 scintigraphy to predict response to therapy in active lupus nephritis.
Lin WY; Lan JL; Wang SJ
J Nucl Med; 1998 Dec; 39(12):2137-41. PubMed ID: 9867157
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study.
van Bommel EF; Siemes C; van der Veer SJ; Han SH; Huiskes AW; Hendriksz TR
J Intern Med; 2007 Aug; 262(2):224-34. PubMed ID: 17645590
[TBL] [Abstract][Full Text] [Related]
29. Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.
Warren GP; Einhorn LH
J Clin Oncol; 1995 Nov; 13(11):2784-8. PubMed ID: 7595739
[TBL] [Abstract][Full Text] [Related]
30. Gallium-67 as a tumor-seeking agent in lymphomas--a review.
Draisma A; Maffioli L; Gasparini M; Savelli G; Pauwels E; Bombardieri E
Tumori; 1998; 84(4):434-41. PubMed ID: 9824994
[TBL] [Abstract][Full Text] [Related]
31. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
[TBL] [Abstract][Full Text] [Related]
32. Delayed positive thallium uptake in large B-cell non-Hodgkin's malignant lymphoma.
Abdel-Dayem HM; Naddaf SY; Omar WS; Aziz M; Gillooley J
J Nucl Med; 1997 Aug; 38(8):1213-5. PubMed ID: 9255153
[TBL] [Abstract][Full Text] [Related]
33. Gallium-67 scintigraphy in lymphoma with bone involvement.
Bar-Shalom R; Israel O; Epelbaum R; Haim N; Ben-Arush M; Ben-Shachar M; Leviov M; Gaitini D; Ben-Haim S; Even-Sapir E
J Nucl Med; 1995 Mar; 36(3):446-50. PubMed ID: 7884507
[TBL] [Abstract][Full Text] [Related]
34. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Howman-Giles R; Uren RF; Shaw PJ
J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
[TBL] [Abstract][Full Text] [Related]
35. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
36. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of low-grade gastric MALT lymphoma and high-grade gastric MALT lymphoma: the clinical value of Ga-67 citrate scintigraphy--a pilot study.
Hsu CH; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(7-8):939-43. PubMed ID: 12449725
[TBL] [Abstract][Full Text] [Related]
38. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
[TBL] [Abstract][Full Text] [Related]
39. Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings.
Uchiyama M; Kantoff PW; Kaplan WD
J Nucl Med; 1994 Oct; 35(10):1624-30. PubMed ID: 7931660
[TBL] [Abstract][Full Text] [Related]
40. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
